• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然β-干扰素对人乳腺癌细胞增殖及类固醇受体水平的影响。

Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells.

作者信息

Sica G, Natoli V, Stella C, Del Bianco S

机构信息

Istituto di Istologia ed Embriologia Generale, Università Cattolica del S. Cuore, Rome, Italy.

出版信息

Cancer. 1987 Nov 15;60(10):2419-23. doi: 10.1002/1097-0142(19871115)60:10<2419::aid-cncr2820601011>3.0.co;2-s.

DOI:10.1002/1097-0142(19871115)60:10<2419::aid-cncr2820601011>3.0.co;2-s
PMID:3664427
Abstract

The effect of natural beta-interferon (beta-IFN) on cell proliferation and steroid receptor level was investigated in CG-5 human breast cancer cell line. beta-interferon determines an appreciable diminution of cell growth, at concentrations ranging from 100 to 1000 IU/ml, which is enhanced when serum content of the culture medium is lowered. Low concentrations of beta-IFN (10-100 IU/ml) produce, after a 5-day treatment, an increase in estrogen receptors (ER) and progesterone receptors (PR). No variation of ER and PR levels is observed when beta-IFN is added directly to the cell homogenate before the assay. Our data suggest that beta-IFN could affect hormone sensitivity through a modification of ER and PR in neoplastic mammary cells.

摘要

在CG-5人乳腺癌细胞系中研究了天然β-干扰素(β-IFN)对细胞增殖和类固醇受体水平的影响。β-干扰素在浓度为100至1000 IU/ml时可使细胞生长明显减少,当培养基的血清含量降低时这种作用增强。低浓度的β-干扰素(10 - 100 IU/ml)在处理5天后可使雌激素受体(ER)和孕激素受体(PR)增加。在测定前将β-干扰素直接添加到细胞匀浆中时,未观察到ER和PR水平的变化。我们的数据表明,β-干扰素可能通过改变肿瘤乳腺细胞中的ER和PR来影响激素敏感性。

相似文献

1
Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells.天然β-干扰素对人乳腺癌细胞增殖及类固醇受体水平的影响。
Cancer. 1987 Nov 15;60(10):2419-23. doi: 10.1002/1097-0142(19871115)60:10<2419::aid-cncr2820601011>3.0.co;2-s.
2
The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.ICI 164384和β-干扰素对乳腺癌细胞系生长及类固醇受体谱的影响
Anticancer Res. 1995 Nov-Dec;15(6B):2557-61.
3
The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
Anticancer Res. 1994 Sep-Oct;14(5A):1779-84.
4
In vitro effects of beta-interferon on steroid receptors and prostaglandin output in human endometrial adenocarcinoma.β-干扰素对人子宫内膜腺癌中类固醇受体及前列腺素分泌的体外作用
J Steroid Biochem. 1988;30(1-6):359-62. doi: 10.1016/0022-4731(88)90123-9.
5
[Expression of oestrogen receptor-beta in invasive breast tumours].[雌激素受体-β在浸润性乳腺癌中的表达]
Magy Onkol. 2004;48(1):63-9. Epub 2004 Apr 23.
6
Enhancement of progesterone receptor levels by interferons in AE-7 endometrial cancer cells.干扰素对AE-7子宫内膜癌细胞中孕激素受体水平的增强作用。
Cancer. 1993 May 1;71(9):2776-81. doi: 10.1002/1097-0142(19930501)71:9<2776::aid-cncr2820710915>3.0.co;2-r.
7
Characterization of steroid hormone sensitivity in human breast cancers maintained ex vivo under organotypical culture conditions.在器官型培养条件下体外维持的人乳腺癌中类固醇激素敏感性的特征分析。
J Cancer Res Clin Oncol. 2000 May;126(5):257-62. doi: 10.1007/s004320050340.
8
Recombinant interferon-alpha 2b affects proliferation, steroid receptors and sensitivity to tamoxifen of cultured breast cancer cells (CG-5).
Anticancer Drugs. 1992 Apr;3(2):147-53.
9
[Cell receptors and proliferation markers in breast cancer].[乳腺癌中的细胞受体与增殖标志物]
Gynakol Rundsch. 1989;29 Suppl 2:400-1.
10
High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.在适应于无雌激素条件下生长的ZR-75-1人乳腺癌细胞系的一个变体中,孕酮受体浓度较高。
Br J Cancer. 1990 Apr;61(4):504-7. doi: 10.1038/bjc.1990.114.

引用本文的文献

1
Downregulation of the splicing regulator NSRP1 confers resistance to CDK4/6 inhibitors via activation of interferon signaling in breast cancer.剪接调节因子NSRP1的下调通过激活乳腺癌中的干扰素信号通路赋予对CDK4/6抑制剂的抗性。
J Biol Chem. 2025 Jan;301(1):108070. doi: 10.1016/j.jbc.2024.108070. Epub 2024 Dec 10.
2
Recombinant Interferon-β in the Treatment of Polycythemia Vera and Related Neoplasms: Rationales and Perspectives.重组干扰素-β在真性红细胞增多症及相关肿瘤治疗中的应用:理论依据与前景
Cancers (Basel). 2022 Nov 9;14(22):5495. doi: 10.3390/cancers14225495.
3
MiR-139 Induces an Interferon-β Response in Prostate Cancer Cells by Binding to RIG-1.
miR-139 通过与 RIG-1 结合诱导前列腺癌细胞产生干扰素-β反应。
Cancer Genomics Proteomics. 2021 May-Jun;18(3):197-206. doi: 10.21873/cgp.20252.
4
Role of β-Interferon Inducer (DEAE-Dextran) in Tumorigenesis by VEGF and NOTCH1 Inhibition along with Apoptosis Induction.β-干扰素诱导剂(二乙氨基乙基葡聚糖)通过抑制血管内皮生长因子(VEGF)和Notch1以及诱导凋亡在肿瘤发生中的作用
Front Pharmacol. 2017 Dec 19;8:930. doi: 10.3389/fphar.2017.00930. eCollection 2017.
5
Antitumour actions of interferons: implications for cancer therapy.干扰素的抗肿瘤作用:对癌症治疗的启示。
Nat Rev Cancer. 2016 Mar;16(3):131-44. doi: 10.1038/nrc.2016.14.
6
Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-ĸB).血管抑素通过激活表皮生长因子受体和核因子-κB(NF-κB)抑制乳腺癌增殖。
Exp Mol Pathol. 2011 Jun;90(3):244-51. doi: 10.1016/j.yexmp.2011.01.002. Epub 2011 Jan 15.
7
IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis.IFNγ 通过调节 STAT1、IFN 调节因子 1、NF-κB、BCL2 家族成员以及 caspase 依赖性凋亡信号通路来恢复乳腺癌对氟维司群的敏感性。
Mol Cancer Ther. 2010 May;9(5):1274-85. doi: 10.1158/1535-7163.MCT-09-1169.
8
Subcutaneously administered recombinant human interleukin-2 and interferon alfa-2a for advanced breast cancer: a phase II study of the Cancer and Leukemia Group B (CALGB 9041).
Invest New Drugs. 2004 Jan;22(1):83-9. doi: 10.1023/b:drug.0000006178.32718.22.
9
Tamoxifen enhances interferon-regulated gene expression in breast cancer cells.他莫昔芬增强乳腺癌细胞中干扰素调节基因的表达。
Mol Cell Biochem. 1997 Feb;167(1-2):169-77. doi: 10.1023/a:1006854110122.
10
Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.他莫昔芬与β-干扰素治疗转移性乳腺癌
Breast Cancer Res Treat. 1996;39(2):235-8. doi: 10.1007/BF01806190.